Salem Media Group Announces the Sale of its Principal Office in Camarillo, CA
CAMARILLO, Calif.–(BUSINESS WIRE)–Salem Media Group, Inc. (OTCQX: SALM) announced today the sale of its principal office in Camarillo, California to... Read more.
American Tower Corporation Announces Participation in Upcoming Investor Conferences
BOSTON–(BUSINESS WIRE)–American Tower Corporation (NYSE: AMT) today announced that it will participate in the following upcoming investor conferences:... Read more.
Albany International Declares Dividend
ROCHESTER, N.H.–(BUSINESS WIRE)–The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.26 per share... Read more.
Federman & Sherwood Investigates Lewis Brothers Bakeries, Inc. for Data Breach
OKLAHOMA CITY–(BUSINESS WIRE)–#FedermanSherwood–The law firm of Federman & Sherwood has initiated an investigation into Lewis Brothers Bakeries,... Read more.
TherapeuticsMD Announces First Quarter 2024 Financial Results
BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical... Read more.
RLI Names Deb Millum as Vice President, Claim
PEORIA, Ill.–(BUSINESS WIRE)–#casualtyinsurance–RLI Corp. (NYSE: RLI) — RLI Corp. announced today the promotion of Deb Millum to Vice President,... Read more.
Ingersoll Rand Successfully Completes $3,300 Million Senior Unsecured Bond Offering and New $2,600 Million Senior Unsecured Revolving Credit Facility, Upgraded One Notch by All Three Rating Agencies
DAVIDSON, N.C.–(BUSINESS WIRE)–Ingersoll Rand Inc. (NYSE: IR) (the “Company” or “Ingersoll Rand”), a global provider of mission-critical flow... Read more.
Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual Meeting
Engineering of X-Editors (XE), Scribe’s proprietary genome editing platform, for potency and specificity enables XE to become the first non-Cas9-based molecule... Read more.
HEI Reports First Quarter 2024 Results
1Q24 Net Income of $42.1 million and Diluted Earnings Per Share (EPS) of $0.38 Utility Continues to Operate Efficiently While Advancing Wildfire Mitigation and Resilience... Read more.
Crawford & Company Board Declares Dividends
ATLANTA–(BUSINESS WIRE)–Crawford & Company® (NYSE: CRD-A and CRD-B) is pleased to announce that on May 10, 2024, at its regular quarterly meeting,... Read more.